Preterm Infants
Cross-source consensus on Preterm Infants from 1 sources and 4 claims.
1 sources · 4 claims
Risks & contraindications
Other
Highlighted claims
- The BALLOON target population is infants born at or before 29 weeks and 6 days of gestation. — Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol
- Preterm-born infants are vulnerable after neonatal unit discharge because lung disease can be worsened by frequent respiratory viral infections. — Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol
- UK record-linkage data found substantially higher lower respiratory tract infection incidence in preterm infants than in term-born controls. — Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol
- Infants with bronchopulmonary dysplasia have reduced later-life forced expiratory volume according to evidence cited in the protocol. — Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol